|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Nanostim Inc. Announces First Series of Implants of Its Novel Leadless Cardiac Pacemaker System
12/20/2012 9:41:51 AM
SUNNYVALE, Calif.--(BUSINESS WIRE)--Nanostim, Inc., a privately-owned developer of miniaturized, leadless pacemakers, today announced the first successful implants of a leadless pacemaker in a series of 11 patients at Homolka Hospital in Prague, Czech Republic. The leadless pacemakers were implanted by Dr. Petr Neuzil, Head of Cardiology at Homolka Hospital, Prague, and Dr. Vivek Reddy, Director of Electrophysiology at Mount Sinai Hospital in New York. The patients were enrolled in the company’s LEADLESS Study, which is designed to examine the safety and effectiveness of the first totally self-contained, leadless pacemaker. The study is a prospective, single-arm, multicenter study that will be conducted in up to eight centers in Europe to gather data in support of CE Mark approval.
|
|
|
|
|
|
|
|
|
|
|